Patents Assigned to PanGenex, Inc.
  • Publication number: 20040137572
    Abstract: The present invention provides vectors and methods for the generation of conditional knockout and knockdown cells and animals. Vectors of the invention may be used to knockout or knockdown an endogenous gene and conditionally regulate the expression of an endogenous or ectopic gene. Accordingly, the invention provides vectors and methods useful for the identification of disease-associated genes, generating animal models of disease, and identifying drug candidates.
    Type: Application
    Filed: December 20, 2003
    Publication date: July 15, 2004
    Applicant: PanGenex, Inc.
    Inventors: Robert E. Finney, Alan Lofquist
  • Publication number: 20040137490
    Abstract: A method for high-throughput genomics analysis, to identify the therapeutic or diagnostic utility of genes, entails the use of a construct to disrupt a gene or alleles of a gene in cells of interest. Arrays of such cells can be used to monitor such disrupted cells phenotypically in the context, for example, of testing drug candidates. Polynucleotides that comprise part of the disrupted genes can be recovered from such “knockout” cells, by virtue of an origin of replication or a host cell selection marker sequence that is part of the construct. The recovered polynucleotides can be used to identify the disrupted genes or to make homologous recombination vectors, which in turn can be employed to make multi-allele knockout cells. Double-stranded RNA molecules designed to target the recovered polynucleotide are used to down-regulate the polynucleotide in vitro and in vivo, following determination of a therapeutically effective dosage of the RNAi molecule.
    Type: Application
    Filed: December 20, 2003
    Publication date: July 15, 2004
    Applicant: PanGenex, Inc.
    Inventors: Robert E. Finney, Alan Lofquist
  • Publication number: 20020123065
    Abstract: A method for high-throughput genomics analysis, to identify the therapeutic or diagnostic utility of genes, entails the use of a construct to disrupt a gene or alleles of a gene in cells of interest. Arrays of such cells can be used to monitor such disrupted cells phenotypically in the context, for example, of testing drug candidates. Polynucleotides that comprise part of the disrupted genes can be recovered from such “knockout” cells, by virtue of an origin of replication or a host cell selection marker sequence that is part of the construct. The recovered polynucleotides can be used to identify the disrupted genes or to make homologous recombination vectors, which in turn can be employed to make multi-allele knockout cells.
    Type: Application
    Filed: March 15, 2002
    Publication date: September 5, 2002
    Applicant: PanGenex, Inc.
    Inventors: Alan Lofquist, Robert E. Finney, David Leung